Source: Annual Congress 2004 - Clinical and related features in pulmonary and extrapulmonary tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. M. Munteanu, V. T. Tudorache, D. M. Cocarla (Timisoara, Romania). Biological parameters evolution in acute renal failure (ARF) patients treated with tuberculostatics drugs. Eur Respir J 2004; 24: Suppl. 48, 2583

Member's Comments

No comment yet.

Related content which might interest you: The evolution of biological parameters on acute renal failure (ARF) patients treated with rifampicin Source: Eur Respir J 2002; 20: Suppl. 38, 365s Year: 2002 Side-effects of antituberculosis drug treatment in patients with chronic renal failure Source: Eur Respir J 2002; 20: 440-443 Year: 2002 Specific features of acute renal failure in rifampicin treated patients for pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 609s Year: 2002 Lung function in patients with chronic renal failure (CRF) Source: Eur Respir J 2004; 24: Suppl. 48, 222s Year: 2004 Acute renal failure due to continuous rifampicin therapy Source: Eur Respir J 2006; 28: Suppl. 50, 848s Year: 2006 Anti-TB aminoglycosides-induced renal failure – a series of 10 patients Source: Annual Congress 2007 - Difficult tuberculosis cases II Year: 2007 Incorporating patients with chronic heart failure (CHF) into pulmonary rehabilitation (PR): a propensity matched analysis Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020 Acute effects of early mobility and respiratory therapy in hospitalised patients with chronic heart failure Source: Annual Congress 2009 - Respiratory physiotherapy assessment Year: 2009 Impact of the duration of renal replacement therapy on the respiratory complications in patients with end-stage renal disease Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Characteristics of pneumonia course at the patients with renal insufficiency receiving hemodialysis Source: Annual Congress 2010 - Unusual pathogens in respiratory infections Year: 2010 Tuberculosis in patients with chronic renal failure Source: Eur Respir J 2006; 28: Suppl. 50, 164s Year: 2006 Predictive factors for weaning from non invasive ventilation (NIV) after acute respiratory failure (ARF) in chronic respiratory insufficiency patients Source: Eur Respir J 2001; 18: Suppl. 33, 30s Year: 2001 Functional assessment of respiration before and after hemodialysis in patients with chronic renal failure Source: Eur Respir J 2006; 28: Suppl. 50, 201s Year: 2006 Pulmonary dysfunctions in end stage chronic renal failure (ESCRF) children on regular hemodialysis: possible risk factors Source: Annual Congress 2007 - Paediatric respiratory physiology in health and disease Year: 2007 Pulmonary hypertension (PH) in end-stage renal (ESRD) patients receiving dialysis: prevalence and clinical significance Source: Eur Respir J 2007; 30: Suppl. 51, 345s Year: 2007 Acute renal failure due to rifampicin during tuberculosis treatment Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007 Short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute respiratory failure Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Effect of acute beta-blocker withholding on the ventilatory efficiency in patients with advanced chronic congestive heart failure Source: Annual Congress 2009 - Novel insights in exercise physiology from cells to humans Year: 2009 The value of immunological methods in the complex diagnostics of TB in chronic renal failure patients in the terminal stage Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019 Impact of hemodialysis on dyspnoea and lung function in patients with chronic renal failure Source: Annual Congress 2008 - Lung function in respiratory disease Year: 2008